Crossmark

Compressive stresses in cancer: characterization and implications for tumour progression and treatment

Published Online: 2024-10-10

Published Print: 2024-11

Authors

Linke, Julia A.

Munn, Lance L.

Jain, Rakesh K. https://orcid.org/0000-0001-7571-3548
License Information

Text and Data Mining valid from 2024-10-10

Version of Record valid from 2024-10-10
More Information

Article History

Accepted: 20 August 2024

First Online: 10 October 2024

Competing interests

: R.K.J. received consultant fees from DynamiCure and SynDevRx; owns equity in Accurius, Enlight and SynDevRx; served on the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund; and received grants from Boehringer Ingelheim and Sanofi. L.L.M. receives equity from Bayer and is a consultant for SimBiosys.

Document is current